SGLT2 Inhibitors in Mitigating Cancer Therapy-Related Cardiac Dysfunction: Expanding the Evidence

Mohamed S. Dabour, Anne H. Blaes, Bhavadharini Ramu, Beshay N. Zordoky

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)876-878
Number of pages3
JournalJACC: CardioOncology
Volume6
Issue number6
DOIs
StatePublished - Dec 2024

Keywords

  • CTRCD
  • SGLT2 inhibitors
  • cancer
  • cardio-oncology
  • cardiotoxicity

PubMed: MeSH publication types

  • Editorial

Cite this